By inhibiting the adverse effects of ET-1 on the heart and blood vessels, these medications have the potential to alleviate heart failure symptoms and improve cardiac function.608 Furthermore, ongoing studies are investigating the applications of ET receptor antagonists in conditions such as coronary artery disease, renal diseases, and vascular remodeling. The gene discussed is EDN1; the disease is heart failure.